LEADER 03660nam 2200637Ia 450 001 9910143311803321 005 20170809173702.0 010 $a1-280-74845-1 010 $a9786610748457 010 $a0-470-76257-8 010 $a1-4443-1289-8 010 $a1-4051-7172-3 035 $a(CKB)1000000000341872 035 $a(EBL)284225 035 $a(OCoLC)476033645 035 $a(SSID)ssj0000117860 035 $a(PQKBManifestationID)11146033 035 $a(PQKBTitleCode)TC0000117860 035 $a(PQKBWorkID)10050118 035 $a(PQKB)10767640 035 $a(MiAaPQ)EBC284225 035 $a(EXLCZ)991000000000341872 100 $a20050311d2005 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCardiovascular imaging$b[electronic resource] $ea handbook for clinical practice /$fedited by Jeroen J. Bax ... [et al.] 210 $aMalden, MA $cBlackwell Pub.$d2005 215 $a1 online resource (312 p.) 225 1 $aThe ESC educational series 300 $aDescription based upon print version of record. 311 $a1-4051-3131-4 320 $aIncludes bibliographical references and index. 327 $aList of contributors; Preface; Foreword; Section one: Valve disease; CHAPTER 1 Mitral stenosis; CHAPTER 2 Mitral regurgitation; CHAPTER 3 Aortic stenosis; CHAPTER 4 Aortic regurgitation; CHAPTER 5 Aortic dissection; CHAPTER 6 Evaluation of prosthetic heart valves; CHAPTER 7 Echocardiography in infective endocarditis; Section two: Coronary artery disease; CHAPTER 8 Coronary imaging and screening; CHAPTER 9 Diagnosis and prognosis in patients with chest pain; CHAPTER 10 Peripheral vascular disease; CHAPTER 11 Risk stratification post-infarction 327 $aCHAPTER 12 Risk stratification before non-cardiac surgerySection three: Heart failure; CHAPTER 13 Acute dyspnea (diastolic, systolic LV dysfunction, and pulmonary embolism); CHAPTER 14 Echocardiographic evaluation of patients with chronic dyspnea; CHAPTER 15 Resynchronization therapy; CHAPTER 16 Hypertrophic cardiomyopathy; CHAPTER 17 Viability in ischemic cardiomyopathy; Section four: Uncommon entities; CHAPTER 18 Cardiac tumors; CHAPTER 19 Evaluation of the transplanted heart; CHAPTER 20 Unusual cardiomyopathies - role of cardiac magnetic resonance imaging 327 $aCHAPTER 21 Myocarditis and pericardial diseaseCHAPTER 22 Congenital heart disease; Index 330 $aThis book is focused on the use of non-invasive imaging in clinical cardiology. Its central theme is the use of different imaging modalities in the routine clinical problems that physicians encounter on a regular basis. Many different clinical issues are discussed, including valvular disease, coronary artery disease, and myocardial and pericardial disease. In these various pathologies, the applications of echocardiography, nuclear imaging, CMR and MSCT are highlighted. The majority of chapters are illustrated with a clinical case study and with moving images, which are contained o 410 0$aESC education series. 606 $aHeart$xImaging$vHandbooks, manuals, etc 606 $aCardiovascular system$xImaging$vHandbooks, manuals, etc 608 $aElectronic books. 615 0$aHeart$xImaging 615 0$aCardiovascular system$xImaging 676 $a616.10754 676 $a616.120754 701 $aBax$b Jeroen J$0946863 712 02$aEuropean Society of Cardiology. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910143311803321 996 $aCardiovascular imaging$92139178 997 $aUNINA LEADER 05459nam 2201453z- 450 001 9910557363903321 005 20220111 035 $a(CKB)5400000000042253 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/77123 035 $a(oapen)doab77123 035 $a(EXLCZ)995400000000042253 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aThe Application of Viruses to Biotechnology 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (296 p.) 311 08$a3-0365-2539-4 311 08$a3-0365-2538-6 330 $aViruses are microscopic agents that exist worldwide and are present in humans, animals, plants, and other living organisms in which they can cause devastating diseases. However, the advances of biotechnology and next-generation sequencing technologies have accelerated novel virus discovery, identification, sequencing, and manipulation, showing that they present unique characteristics that place them as valuable tools for a wide variety of biotechnological applications. Many applications of viruses have been used for agricultural purposes, namely concerning plant breeding and plant protection. Nevertheless, it is interesting to mention that plants have also many advantages to be used in vaccine production, such as the low cost and low risks they entail, showing once more the versatility of the use of viruses in biotechnology. Although it will obviously never be ignored that viruses are responsible for devastating diseases, it is clear that the more they are studied, the more possibilities they offer to us. They are now on the front line of the most revolutionizing techniques in several fields, providing advances that would not be possible without their existence. In this book there are presented studies that demonstrate the work developed using viruses in biotechnology. These studies were brought by experts that focus on the development and applications of many viruses in several fields, such as agriculture, the pharmaceutical industry, and medicine. 606 $aTechnology: general issues$2bicssc 610 $aAAV 610 $aadeno-associated virus 610 $aadeno-associated virus (AAV) vector 610 $aapple latent spherical virus vector 610 $aaspect ratio 610 $abacmid 610 $aBacteriophage 610 $abaculovirus 610 $abiocontrol 610 $abioreactor 610 $abreeding of grapevine 610 $acancer 610 $acancer gene therapy 610 $acancers 610 $acarotenoid biosynthesis 610 $achemokines 610 $achikungunya virus 610 $acircular RNA 610 $aclodronate 610 $acodon harmonization 610 $acodon optimization 610 $acomparative genomics 610 $aCOVID-19 610 $aCOVID-19 vaccines 610 $aCPMV 610 $aCRISPR 610 $aCRISPR-cas9 610 $aCRISPR/Cas systems 610 $aCRISPR/Cas9 610 $adiagnosis 610 $aDNA-based vaccines 610 $aenhancer 610 $aEscherichia coli 610 $aexpression vectors 610 $ageminivirus 610 $agene editing 610 $agene expression 610 $agene therapy 610 $agenome editing 610 $agenome stability 610 $agrapevine 610 $aheterologous expression 610 $ahydrothermal vent 610 $aHypnocyclicus thermotrophus 610 $aimmunization 610 $ainfectious bursal disease virus 610 $ainfectious diseases 610 $ainsect cells 610 $ajaagsiekte sheep retrovirus (JSRV) 610 $aLTR 610 $alytic cassette 610 $amacrophage 610 $ananotechnology 610 $aNewcastle disease virus 610 $aphage diversity 610 $aphages 610 $apig 610 $aplant genome engineering 610 $aplant virus 610 $aporcine epidemic diarrhea virus 610 $aprevention 610 $aprophage 610 $aprotein expression 610 $aPVX 610 $arecombinant Lactococcus lactis 610 $areduced generation time 610 $areverse genetics 610 $aRNA-based vaccines 610 $aSalmonella 610 $aSARS-CoV-2 610 $aself-replicating RNA vectors 610 $atheranostics 610 $aTMV 610 $aTn7 610 $atransduction 610 $atreatment 610 $avaccine 610 $avaccines 610 $avariant strain 610 $aviral resistance 610 $aviral vaccines 610 $aviral vector 610 $aviral vectors 610 $aviroid 610 $avirus elimination 610 $avirus-induced flowering 610 $avirus-induced gene silencing (VIGS) 610 $aviruses 610 $aVLP 610 $aVLPs 610 $aVNPs 615 7$aTechnology: general issues 700 $aVaranda$b Carla$4edt$01302211 702 $aMateratski$b Patrick$4edt 702 $aVaranda$b Carla$4oth 702 $aMateratski$b Patrick$4oth 906 $aBOOK 912 $a9910557363903321 996 $aThe Application of Viruses to Biotechnology$93026255 997 $aUNINA